Navigation Links
Loosen leash on cancer protein 'watchdog,' researchers say

Scientists may have found a way to keep a protein "watchdog" on high alert to stop hereditary cancers from overrunning our bodies - if they can keep it on a leash of just the right length.

In a collaborative effort, a team of scientists including Purdue University's Susan M. Mendrysa has found that one of the proteins found naturally in cells has the ability to halt the progression of intestinal tumors that arise from genetic predisposition. When the activity of this protein, known only by the technical name of p53, was artificially increased in the cells of laboratory mice, those known to have a hereditary predisposition for developing cancer showed a marked decrease in tumor development when compared with mice that had normal p53 activity.

The study also indicated that the treated mice did not suffer from the side effect the research team most feared: premature aging, which has been linked to overproduction of p53 in other studies. The discovery could assist in future human cancer treatments.

"It's a question of balance," said Mendrysa (pronounced men-DRISS-ah), who is an assistant professor of basic medical sciences in Purdue's College of Veterinary Medicine and co-lead author of the work. "The p53 protein has been long known as an effective weapon against cancers, but we know from previous research that we can't just let it run rampant through the body without some very unpleasant side effects. But if we can give it just enough slack in its leash, it could help some patients from cancer-prone families from ever developing the disease."

The team's research appears in the Jan. 1 issue of the scientific journal Genes and Development. Members of the group include the University of Wisconsin - Madison's Kathleen A. O'Leary (co-lead author), Matthew K. McElwee and Jennifer Michalowski; the Fred Hutchinson Cancer Research Center's Robert N. Eisenman; and the National Cancer Institute's Mary Ellen Perry and Douglas A. Powell. When the grou
'"/>

Source:Purdue University


Page: 1 2 3 4

Related biology news :

1. Loosen up, DNA: Leukemia gene changes genetic packaging
2. How an AIDS-Related Cancer Unleashes Inflammation
3. Viral DNA sequence a possible trigger for breast cancer
4. Enzyme, lost in most mammals, is shown to protect against UV-induced skin cancer
5. Its not all genetic: Common epigenetic problem doubles cancer risk in mice
6. Columbia research lifts major hurdle to gene therapy for cancer
7. Combination therapy boosts effectiveness of telomere-directed cancer cell death
8. Mitochondrial DNA mutations play significant role in prostate cancer
9. New imaging method gives early indication if brain cancer therapy is effective, U-M study shows
10. BRCA1 causes ovarian cancer through indirect, biochemical route
11. Researchers identify target for cancer drugs

Post Your Comments:
(Date:11/24/2009)...ribed by traditional healers in Brazil to treat a ...to fever and flu. , Now for the first time, resea...cientifically prove the pain relieving properties ...mint. , Testing this ancient South American herb ... was able to show that when prepared as a ,tea, t...
(Date:11/24/2009)...class of ring-shaped protein motors has been uncov...ional Laboratory (Berkeley Lab) using a state-of-t...anced Light Source (ALS). These protein motors pla..., and are vital to the survival of all biological ...uman papillomavirus, which has been linked to cerv...
(Date:11/24/2009)...research on bacterial communities throughout six l...emporal patterns, suggesting that scientists could...limate change in the polar regions. The study, pub...al Academy of Sciences Early Edition, shows that ...nchronously over time, correlating with seasonal s...
Breaking Biology News(10 mins):Got a pain? -- Have a cup of Brazilian mint 2Atomic-level snapshot catches protein motor in action 2Atomic-level snapshot catches protein motor in action 3Atomic-level snapshot catches protein motor in action 4Researchers establish common seasonal pattern among bacterial communities in Arctic rivers 2A case of cecal volvulus 48622 1The BBVA Foundation presents its Frontiers of Knowledge Awards 8801 1The BBVA Foundation presents its Frontiers of Knowledge Awards 8801 2Catholic Charities Executive to Speak at Caritas Internationalis 48619 1Catholic Charities Executive to Speak at Caritas Internationalis 48619 2
... conversion" provides a modern-day snapshot of how...ut of the earliest primordial mix of RNA-like mole...-into a more complex form of RNA-based life (or th...ed on DNA and proteins. Nucleic acids are large co...rmation, but can also function as enzymes. , While...
...e got a bad boss, one who loves to chew people out...thankful you are not a wasp. , If you were, chance... that it is time to leave the nest and forage for ...of Washington animal behaviorist. Biting is a way...ia occidentalis recruit new foragers to gather wat...
... conducted at the Salk Institute for Biological St...ent to date considered to be largely successful, i...earchers, led by Inder Verma, Ph.D., a professor i...healthy copy, which replaces the defective gene ca...s appear in this week,s issue of the journal Natur...
Other Biology News:'Accelerated evolution' converts RNA enzyme to DNA enzyme in vitro 2'Accelerated evolution' converts RNA enzyme to DNA enzyme in vitro 3Taking a bite out of a fellow worker helps wasps recruit new foragers 2Mouse study reveals human X-SCID gene therapy poses substantial cancer risk 2Mouse study reveals human X-SCID gene therapy poses substantial cancer risk 3
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/ -... & Trademark Office (PTO) has allowed the pate... or NOD technology. , NOD technology is a... or,proteins into bio-adhesive nano-particles to e...d as injections. NOD technology is a platform tech...
(Date:11/24/2009)... , SHANGHAI, Nov. 24 /PRNewswire-Asia/...ood & Drug Administration (SFDA) has approved ... its oral insulin project,(Nodlin), an innovative ...proval allows Biolaxy to initiate its first phase ...r characteristic of high blood glucose and poor,me...
(Date:11/24/2009)... The FBI recently approved the ...ries participating in or generating DNA records fo... Madison, WI USA (PRWEB) -- The FBI recen...tem for use by laboratories participating in, or ... System (NDIS). NDIS currently contains more than ...
(Date:11/24/2009)... , TSX VENTURE: HTL , TORONTO, Nov. 24 /P...: HTL), formerly Calotto Capital Inc., a leading p...for the stem cell research and fertility clinic ma...sults for the third quarter ended September 30, 20...s $1.46 million compared with $1.43 million in Q3 ...
Breaking Biology Technology:Biolaxy Secures IND Approval for Oral Insulin 2NDIS Approval of Promega PowerPlex Kit Clears Path for More DNA Profiles to be Added to U.S. Database 2Hamilton Thorne announces third quarter results 2Hamilton Thorne announces third quarter results 3Hamilton Thorne announces third quarter results 4Hamilton Thorne announces third quarter results 5Hamilton Thorne announces third quarter results 6Hamilton Thorne announces third quarter results 7Hamilton Thorne announces third quarter results 8Hamilton Thorne announces third quarter results 9Hamilton Thorne announces third quarter results 10
...y International, LLC,(BioEnergy), a privately-held...ation, renewable biochemicals and biofuels, announ...rd of Advisors effective December,2008. Mr. August...nnovation,at the highest level of industry and gov...ief Executive Officer of Lockheed Martin, the nati...
...aceuticals Plc, a,biopharmaceutical company focuse...ugs, announced today the results of the ongoing,sc... MD Biosciences,Immunoprofiler(TM) in vitro screen... identify and assess the anti-inflammatory propert...inflammatory compounds. The,Immunoprofiler(TM) Scr...
...Orthocrat Ltd., announced,today that the George Wa...ad(TM), a web-based pre-operative planning and dig...rgeons have traditionally used X-ray films and ace...implants when planning for,joint-replacement surge...ies for x-rays, TraumaCad will allow the orthopaed...
Other Biology Technology:BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 2BioEnergy International, LLC Announces Norman R. Augustine to Join Advisory Board 3Morria Biopharmaceuticals Plc Announces Results From its Pre-Clinical Screening of Novel Anti-Inflammatory Compounds 2George Washington University Hospital Purchases Orthocrat's TraumaCad(TM) for Orthopedic Preoperative Planning 2George Washington University Hospital Purchases Orthocrat's TraumaCad(TM) for Orthopedic Preoperative Planning 3
UV LAMP 300 NM 8W T5 from GE Healthcare, formerly Amersham Biosciences
DePsipher Mitochondrial Membrane Potential Disruption Kit from R&D Systems
EGTA; AM; 10mM DMSO solution from AnaSpec
Mouse Anti-Human COMPLEMENT SC5B-9 (NEOANTIGEN) Monoclonal Antibody, Unconjugated, Clone 3R2/0 from AbD Serotec
Biology Products: